# OnCo record paper-mody-biliary-ctdna-profiling-jco-po-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mody-biliary-ctdna-profiling-jco-po-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mody-biliary-ctdna-profiling-jco-po-2019" ;
  schema:name "Circulating tumor DNA profiling of advanced biliary tract cancers"@en ;
  schema:description "Blood tests for tumour DNA found a mutation in three quarters of 124 patients with advanced bile duct or gallbladder cancer and a drug-relevant change in about half, showing the approach is feasible when tissue is hard to get."@en ;
  schema:url <https://onco.cc/key-papers/paper-mody-biliary-ctdna-profiling-jco-po-2019/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/po.18.00324>, <https://pubmed.ncbi.nlm.nih.gov/35100741/> ;
  schema:sameAs <https://doi.org/10.1200/po.18.00324> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Mody K, Kasi PM, Yang J, et al." ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/braf/>, <https://onco.cc/targets/fgfr2/>, <https://onco.cc/targets/idh/> ;
  onco:drugs <https://onco.cc/drugs/guardant360-cdx/> ;
  onco:companies <https://onco.cc/companies/guardant-health/> ;
  onco:institutions <https://onco.cc/institutions/mayo-clinic/> ;
  onco:terms <https://onco.cc/terms/ctdna/> ;
  onco:journals <https://onco.cc/journals/jco-precision-oncology/> .